LTC4S
LTC4S (leukotriene C4 synthase) is a membrane-associated enzyme of the MAPEG family that catalyses the first step in cysteinyl leukotriene biosynthesis. It conjugates leukotriene A4 with reduced glutathione to form leukotriene C4, a potent mediator derived from arachidonic acid. Browse Assay Genie's current range of LTC4S research reagents below, or read on for the biology behind the target.
LTC4S catalyses the conjugation of leukotriene A4 with reduced glutathione (GSH) to form leukotriene C4, and it does so with high specificity. This reaction is the first step in the biosynthesis of the cysteinyl leukotrienes, potent biological compounds derived from arachidonic acid. The enzyme can also transfer a glutathionyl group from GSH to 13(S),14(S)-epoxy-docosahexaenoic acid, producing maresin conjugate in tissue regeneration 1 (MCTR1). MCTR1 is a bioactive lipid mediator with potent anti-inflammatory and proresolving actions, so LTC4S sits at a point where pro-inflammatory and pro-resolving lipid pathways meet.
The LTC4S gene encodes a member of the MAPEG superfamily, named for Membrane Associated Proteins in Eicosanoid and Glutathione metabolism. Several human MAPEG proteins are involved in the production of leukotrienes. The LTC4S protein localises to the nuclear envelope, including the outer nuclear membrane, and to the adjacent endoplasmic reticulum membrane. Orthologues are annotated in mouse and rat, both named Ltc4s, which allows the enzyme to be studied in rodent models. The gene symbol MGC33147 appears as an earlier alias.
Leukotrienes have been implicated as mediators of anaphylaxis and of inflammatory conditions such as human bronchial asthma. Because LTC4S acts at the committed step of cysteinyl leukotriene formation, researchers study the LTC4S gene and protein when examining eicosanoid signalling, glutathione-dependent lipid metabolism and the balance between inflammation and its resolution.
LTC4S catalyses the first step in cysteinyl leukotriene production, making it a focal enzyme for dissecting arachidonic acid metabolism.
Leukotrienes are implicated as mediators of anaphylaxis and human bronchial asthma, which makes LTC4S relevant to airway and allergic inflammation studies.
LTC4S can form MCTR1, a lipid mediator with anti-inflammatory and proresolving actions, linking the enzyme to tissue regeneration research.
As a MAPEG member acting on glutathione conjugation, LTC4S is studied in membrane-associated eicosanoid and glutathione metabolism.
LTC4S catalyses the conjugation of leukotriene A4 with reduced glutathione to form leukotriene C4, the first step in cysteinyl leukotriene biosynthesis. It can also transfer glutathione to 13(S),14(S)-epoxy-docosahexaenoic acid to form MCTR1, a proresolving lipid mediator.
LTC4S is the symbol for leukotriene C4 synthase, with MGC33147 listed as an alias. The enzyme carries EC number 4.4.1.20 and belongs to the MAPEG superfamily, which stands for Membrane Associated Proteins in Eicosanoid and Glutathione metabolism.
Mouse and rat both have an orthologue named Ltc4s, so rodent models can be used; check the datasheet of any product for its validated reactivity. Its products, the leukotrienes, are implicated in anaphylaxis and inflammatory conditions such as human bronchial asthma.
Other MAPEG family members, leukotriene pathway enzymes and cysteinyl leukotriene receptors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q16873; product specifications from Assay Genie datasheets.